Capillary regeneration in scleroderma: stem cell therapy reverses phenotype?
Scleroderma is an autoimmune disease with a characteristic vascular pathology. The vasculopathy associated with scleroderma is one of the major contributors to the clinical manifestations of the disease.We used immunohistochemical and mRNA in situ hybridization techniques to characterize this vascul...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2008-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC2175530?pdf=render |
| _version_ | 1819161721029263360 |
|---|---|
| author | Jo N Fleming Richard A Nash D O McLeod David F Fiorentino Howard M Shulman M Kari Connolly Jerry A Molitor Gretchen Henstorf Robert Lafyatis David K Pritchard Lawrence D Adams Daniel E Furst Stephen M Schwartz |
| author_facet | Jo N Fleming Richard A Nash D O McLeod David F Fiorentino Howard M Shulman M Kari Connolly Jerry A Molitor Gretchen Henstorf Robert Lafyatis David K Pritchard Lawrence D Adams Daniel E Furst Stephen M Schwartz |
| author_sort | Jo N Fleming |
| collection | DOAJ |
| description | Scleroderma is an autoimmune disease with a characteristic vascular pathology. The vasculopathy associated with scleroderma is one of the major contributors to the clinical manifestations of the disease.We used immunohistochemical and mRNA in situ hybridization techniques to characterize this vasculopathy and showed with morphometry that scleroderma has true capillary rarefaction. We compared skin biopsies from 23 scleroderma patients and 24 normal controls and 7 scleroderma patients who had undergone high dose immunosuppressive therapy followed by autologous hematopoietic cell transplant. Along with the loss of capillaries there was a dramatic change in endothelial phenotype in the residual vessels. The molecules defining this phenotype are: vascular endothelial cadherin, a supposedly universal endothelial marker required for tube formation (lost in the scleroderma tissue), antiangiogenic interferon alpha (overexpressed in the scleroderma dermis) and RGS5, a signaling molecule whose expression coincides with the end of branching morphogenesis during development and tumor angiogenesis (also overexpressed in scleroderma skin. Following high dose immunosuppressive therapy, patients experienced clinical improvement and 5 of the 7 patients with scleroderma had increased capillary counts. It was also observed in the same 5 patients, that the interferon alpha and vascular endothelial cadherin had returned to normal as other clinical signs in the skin regressed, and in all 7 patients, RGS5 had returned to normal.These data provide the first objective evidence for loss of vessels in scleroderma and show that this phenomenon is reversible. Coordinate changes in expression of three molecules already implicated in angiogenesis or anti-angiogenesis suggest that control of expression of these three molecules may be the underlying mechanism for at least the vascular component of this disease. Since rarefaction has been little studied, these data may have implications for other diseases characterized by loss of capillaries including hypertension, congestive heart failure and scar formation. |
| first_indexed | 2024-12-22T17:16:50Z |
| format | Article |
| id | doaj.art-2e87b1557c3b4ba982bf4c91315e952c |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-22T17:16:50Z |
| publishDate | 2008-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-2e87b1557c3b4ba982bf4c91315e952c2022-12-21T18:18:56ZengPublic Library of Science (PLoS)PLoS ONE1932-62032008-01-0131e145210.1371/journal.pone.0001452Capillary regeneration in scleroderma: stem cell therapy reverses phenotype?Jo N FlemingRichard A NashD O McLeodDavid F FiorentinoHoward M ShulmanM Kari ConnollyJerry A MolitorGretchen HenstorfRobert LafyatisDavid K PritchardLawrence D AdamsDaniel E FurstStephen M SchwartzScleroderma is an autoimmune disease with a characteristic vascular pathology. The vasculopathy associated with scleroderma is one of the major contributors to the clinical manifestations of the disease.We used immunohistochemical and mRNA in situ hybridization techniques to characterize this vasculopathy and showed with morphometry that scleroderma has true capillary rarefaction. We compared skin biopsies from 23 scleroderma patients and 24 normal controls and 7 scleroderma patients who had undergone high dose immunosuppressive therapy followed by autologous hematopoietic cell transplant. Along with the loss of capillaries there was a dramatic change in endothelial phenotype in the residual vessels. The molecules defining this phenotype are: vascular endothelial cadherin, a supposedly universal endothelial marker required for tube formation (lost in the scleroderma tissue), antiangiogenic interferon alpha (overexpressed in the scleroderma dermis) and RGS5, a signaling molecule whose expression coincides with the end of branching morphogenesis during development and tumor angiogenesis (also overexpressed in scleroderma skin. Following high dose immunosuppressive therapy, patients experienced clinical improvement and 5 of the 7 patients with scleroderma had increased capillary counts. It was also observed in the same 5 patients, that the interferon alpha and vascular endothelial cadherin had returned to normal as other clinical signs in the skin regressed, and in all 7 patients, RGS5 had returned to normal.These data provide the first objective evidence for loss of vessels in scleroderma and show that this phenomenon is reversible. Coordinate changes in expression of three molecules already implicated in angiogenesis or anti-angiogenesis suggest that control of expression of these three molecules may be the underlying mechanism for at least the vascular component of this disease. Since rarefaction has been little studied, these data may have implications for other diseases characterized by loss of capillaries including hypertension, congestive heart failure and scar formation.http://europepmc.org/articles/PMC2175530?pdf=render |
| spellingShingle | Jo N Fleming Richard A Nash D O McLeod David F Fiorentino Howard M Shulman M Kari Connolly Jerry A Molitor Gretchen Henstorf Robert Lafyatis David K Pritchard Lawrence D Adams Daniel E Furst Stephen M Schwartz Capillary regeneration in scleroderma: stem cell therapy reverses phenotype? PLoS ONE |
| title | Capillary regeneration in scleroderma: stem cell therapy reverses phenotype? |
| title_full | Capillary regeneration in scleroderma: stem cell therapy reverses phenotype? |
| title_fullStr | Capillary regeneration in scleroderma: stem cell therapy reverses phenotype? |
| title_full_unstemmed | Capillary regeneration in scleroderma: stem cell therapy reverses phenotype? |
| title_short | Capillary regeneration in scleroderma: stem cell therapy reverses phenotype? |
| title_sort | capillary regeneration in scleroderma stem cell therapy reverses phenotype |
| url | http://europepmc.org/articles/PMC2175530?pdf=render |
| work_keys_str_mv | AT jonfleming capillaryregenerationinsclerodermastemcelltherapyreversesphenotype AT richardanash capillaryregenerationinsclerodermastemcelltherapyreversesphenotype AT domcleod capillaryregenerationinsclerodermastemcelltherapyreversesphenotype AT davidffiorentino capillaryregenerationinsclerodermastemcelltherapyreversesphenotype AT howardmshulman capillaryregenerationinsclerodermastemcelltherapyreversesphenotype AT mkariconnolly capillaryregenerationinsclerodermastemcelltherapyreversesphenotype AT jerryamolitor capillaryregenerationinsclerodermastemcelltherapyreversesphenotype AT gretchenhenstorf capillaryregenerationinsclerodermastemcelltherapyreversesphenotype AT robertlafyatis capillaryregenerationinsclerodermastemcelltherapyreversesphenotype AT davidkpritchard capillaryregenerationinsclerodermastemcelltherapyreversesphenotype AT lawrencedadams capillaryregenerationinsclerodermastemcelltherapyreversesphenotype AT danielefurst capillaryregenerationinsclerodermastemcelltherapyreversesphenotype AT stephenmschwartz capillaryregenerationinsclerodermastemcelltherapyreversesphenotype |